GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » UXN Co Ltd (XKRX:337840) » Definitions » Capex-to-Revenue

UXN Co (XKRX:337840) Capex-to-Revenue : 1.23 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is UXN Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

UXN Co's Capital Expenditure for the six months ended in Dec. 2024 was ₩-631.09 Mil. Its Revenue for the six months ended in Dec. 2024 was ₩513.47 Mil.

Hence, UXN Co's Capex-to-Revenue for the six months ended in Dec. 2024 was 1.23.


UXN Co Capex-to-Revenue Historical Data

The historical data trend for UXN Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UXN Co Capex-to-Revenue Chart

UXN Co Annual Data
Trend Dec22 Dec23 Dec24
Capex-to-Revenue
29.15 4.02 1.23

UXN Co Semi-Annual Data
Dec22 Dec23 Dec24
Capex-to-Revenue 29.15 4.02 1.23

Competitive Comparison of UXN Co's Capex-to-Revenue

For the Medical Devices subindustry, UXN Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UXN Co's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, UXN Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where UXN Co's Capex-to-Revenue falls into.


;
;

UXN Co Capex-to-Revenue Calculation

UXN Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-631.093) / 513.465
=1.23

UXN Co's Capex-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-631.093) / 513.465
=1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


UXN Co  (XKRX:337840) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


UXN Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of UXN Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


UXN Co Business Description

Traded in Other Exchanges
N/A
Address
No. 614, No. 1, 379, Green-ro, Jeollanam-do, Naju, KOR, 58325
UXN Co Ltd is a medical device company. It is engaged in the production of Blood glucose sensors, and blood glucose meter.

UXN Co Headlines

No Headlines